Company Filing History:
Years Active: 1986-1990
Title: Gene W Holbert: Innovator in Pharmaceutical Treatments
Introduction
Gene W Holbert is a notable inventor based in Loveland, OH (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of hyperaldosteronism and related disorders. With a total of 6 patents to his name, Holbert's work has had a meaningful impact on medical science.
Latest Patents
One of Holbert's latest patents is a method of treatment using 18-cyanoprogesterone derivatives. This invention is directed towards a method for treating hyperaldosteronism, which involves administering an appropriate 18-cyanopregnane to patients. Another significant patent involves 19-fluoro- and cyano-substituted 21-hydroxyprogesterone derivatives. These compounds are described as active 19-hydroxylase inhibitors and are useful as antihypertensive agents. The preparation of these compounds utilizes various synthetic pathways depending on the specific 19-substituted progesterone or related compound desired.
Career Highlights
Throughout his career, Gene W Holbert has worked with prominent companies such as Merrell Dow Pharmaceuticals and John O. Johnston. His experience in these organizations has allowed him to develop and refine his innovative ideas in the pharmaceutical industry.
Collaborations
Some of Holbert's notable coworkers include J O'Neal Johnston and Joseph P Burkhart. Their collaboration has contributed to the advancement of research and development in the field.
Conclusion
Gene W Holbert's contributions to pharmaceutical innovations demonstrate his commitment to improving medical treatments. His patents reflect a deep understanding of complex biochemical processes and a dedication to enhancing patient care.